NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)

RecruitingPhase 1

Sponsor: Yale University

Conditions: Hiv, Alcohol Drinking, Fall, Cannabis Use

Interventions: Information Motivation Behavioral and Motivational Interviewing (IMB-MI) technique

Countries: United States

The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may interact with neurocognitively active medications, alcohol, and cannabis use leading to falls and impaired cognition.

Eligibility overview

Sex: ALL

Age: 50 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* HIV+
* have visited a local VA site in within the past year
* had an AUDIT-C indicating current alcohol use
* taking 5 or more non-ART medications, including an NCAM (i.e., benzodiazepines, opioids, muscle relaxants, sleeping medication, and selective serotonin reuptake inhibitors)

Exclusion Criteria:

* Inpatient individuals
* Patients with an Alcohol Use Disorder (AUD) diagnosis in the past 12 months
* Patients who test positive on the Alcohol Symptom Checklist for moderate or severe AUD during the screening process

Locations (1)

West Haven, Connecticut, United States